Postoperative amenorrhoea at 12 months or less · women with heavy menstrual bleeding
It is very uncertain whether gnRH analogues changes postoperative amenorrhoea at 12 months or less compared with placebo or no treatment (very low certainty).
1 finding from 1 review
RR 1.58 [1.24, 2.01]
605 participants
Very low
Postoperative amenorrhoea at 12 months or less · women with heavy menstrual bleeding
It is very uncertain whether gnRH analogues changes postoperative amenorrhoea at 12 months or less compared with danazol (very low certainty).
1 finding from 1 review
RR 1.17 [0.9, 1.52]
340 participants
Very low
Postoperative amenorrhoea at 12 months or less · women with heavy menstrual bleeding
It is very uncertain whether gnRH analogues changes postoperative amenorrhoea at 12 months or less compared with progestogens (very low certainty).
1 finding from 1 review
RR 1.58 [0.96, 2.61]
146 participants
Very low
GnRHas vs gestrinone Percentage change values ‐ 12 months · Women with endometriosis, treated with GnRHas with effect on bone mineral density
2 findings from 1 review
GnRHas vs GnRHas in conjunction with calcium‐regulating agents Anterior‐posterior spine ‐ 12 months · Women with endometriosis, treated with GnRHas with effect on bone mineral density
1 finding from 1 review
GnRHas vs GnRHas in conjunction with calcium‐regulating agents Lateral spine ‐ 12 months · Women with endometriosis, treated with GnRHas with effect on bone mineral density
1 finding from 1 review
Quality of life · patients with uterine fibroids
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Bone density (SMD) ‐ · patients with uterine fibroids
1 finding from 1 review
Uterine size (cm3) ‐ · patients with uterine fibroids
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Uterine bleeding · patients with uterine fibroids
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Severity of vasomotor symptoms · patients with uterine fibroids
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Rate of vasomotor symptoms ‐ · patients with uterine fibroids
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Uterine bleeding · patients with uterine fibroids
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Severity of vasomotor symptoms · patients with uterine fibroids
1 finding from 1 review
Rate of vasomotor symptoms ‐ · patients with uterine fibroids
GnRH‐a + tibolone showed no clear difference in rate of vasomotor symptoms ‐ compared with gnRH‐a ± placebo (low certainty).
1 finding from 1 review
QoL · patients with uterine fibroids
1 finding from 1 review
Bone density (SMD) ‐ · patients with uterine fibroids
1 finding from 1 review
Uterine size (cm3) ‐ · patients with uterine fibroids
1 finding from 1 review
QoL · patients with uterine fibroids
1 finding from 1 review
Bone density (SMD) ‐ · patients with uterine fibroids
1 finding from 1 review